Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Treatment Options for Patients With Heavily Pretreated Relapsed and Refractory Multiple Myeloma — Meletios A Dimopoulos (2022) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Treatment Options for Patients With Heavily Pretreated Relapsed and Refractory Multiple Myeloma
Shared by
Meletios A Dimopoulos
Treatment Options for Patients With Heavily Pretreated Relapsed and Refractory Multiple Myeloma
Article
2022
en
Authors
Meletios A Dimopoulos
PR
Paul G. Richardson
SL
Sagar Lonial
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2022
DUPLICATE: Treatment Options for Patients With Heavily Pretreated Relapsed and Refractory Multiple Myeloma
Meletios A Dimopoulos
,
Paul G. Richardson
,
Sagar Lonial
Article
2015
Treatment options for relapsed and refractory multiple myeloma
Ajay K. Nooka
,
Efstathios Kastritis
,
Meletios A Dimopoulos
,
Sagar Lonial
Article
2022
An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment
Meletios A Dimopoulos
,
Joseph Mıkhael
,
Evangelos Terpos
,
Xavier Leleu
,
Philippe Moreau
,
Joan Bladé
,
Jin Seok Kim
,
Keith Stockerl‐Goldstein
,
Paul G. Richardson
Chapter in a book
2017
Treatment of Relapsed/Refractory Patients with Multiple Myeloma
Jacob P. Laubach
,
Philippe Moreau
,
Meletios A Dimopoulos
,
Paul G. Richardson
Article
2009
Treatment of Relapsed/Refractory Multiple Myeloma
Efstathios Kastritis
,
Antonio Palumbo
,
Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.